The data point was not buried
Patients were then randomized to one of two treatment sequences: 1) VYVANSE (optimized dose) followed by placebo, each for one week, or 2) placebo followed by VYVANSE, each for one week
Twice-weekly protocols (0.51ml every 34 days) are appropriate during active weight loss phases or when treating hepatic steatosis but are not necessary for maintenance
Dosage and Frequency: The higher the dosage and frequency, the higher the cost of the treatment will be, but your skincare expert will decide that
Co-immunoprecipitaton 48 h post transfection, cells were washed by PBS and collected into lysis buffer (Beyotime, P0013) with PMSF (Roche, 10837091001) and protease inhibitor (Merck, 539134) freshly added
Not everyone with HS will see improvement, but weight management is a key part of care